SVA
Sinovac Biotech Ltd
6.50$
+0.0%
vs. previous close
Closing price · As of: Sep 12, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q4 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +240.0% | +120.6% | +183.6% | +0.0% | +3,253.5% | -23.6% | -85.6% | -76.9% | +499.7% | -91.7% | +119.3% | |
| – | +281.7% | +86.7% | +208.4% | +0.0% | +1,351.5% | -30.3% | -42.3% | +69.1% | +203.1% | -85.5% | – | |
| – | +233.8% | +126.4% | +180.2% | +0.0% | +3,545.0% | -23.2% | -88.0% | -115.6% | – | -112.7% | – | |
| – | +153.9% | +79.5% | -89.7% | +0.0% | +1,926.0% | +87.6% | +82.3% | +39.8% | +54.8% | -62.1% | +28.0% | |
| – | +85.5% | +53.7% | +75.8% | – | – | – | – | – | – | – | – | |
| – | +102.1% | +63.7% | +18.1% | +0.0% | +148.6% | +146.8% | -36.0% | +172.3% | +15.1% | -64.2% | -3.2% | |
| – | – | – | +609.3% | +0.0% | +5,045.9% | -26.8% | -91.7% | -274.8% | – | – | – | |
| – | +68.8% | +42.4% | -38.2% | +0.0% | +364.0% | -13.7% | -52.6% | +2.9% | +289.4% | -89.4% | +656.1% | |
| – | – | – | +639.8% | +0.0% | +3,266.6% | -26.7% | -87.3% | -191.8% | – | – | – | |
| – | – | +383.9% | +353.3% | +0.0% | +6,017.0% | -2.3% | -91.1% | -246.3% | – | – | – | |
| – | – | – | +1,447.4% | -37.0% | +4,593.9% | -34.2% | -85.6% | -176.5% | – | – | -790.6% | |
| – | – | +1,367.0% | +622.7% | -0.1% | +4,980.4% | -26.4% | -90.7% | -218.3% | – | – | -229.0% |
Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.